WallStreetZenWallStreetZen

NYSEMKT: MAIA
Maia Biotechnology Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their MAIA stock forecasts and price targets.

Forecast return on equity

Is MAIA forecast to generate an efficient return?

Company
-423.1%
Industry
26.15%
Market
56.47%
MAIA's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is MAIA forecast to generate an efficient return on assets?

Company
-176.26%
Industry
10.01%
MAIA is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

MAIA earnings per share forecast

What is MAIA's earnings per share in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$0.72
Avg 2 year Forecast
-$0.69

MAIA revenue forecast

What is MAIA's revenue in the next 1 years based on estimates from 1 analyst?

Avg 1 year Forecast
$66.3M

MAIA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
MAIA$1.85N/AN/A
FBIO$1.88$16.00+751.06%Strong Buy
UNCY$4.60$75.00+1,530.43%Strong Buy
ANL$1.50N/AN/A
SNTI$2.20$8.50+286.36%Strong Buy
View Top Biotech Stocks

Maia Biotechnology Stock Forecast FAQ

What is MAIA's earnings growth forecast for 2025-2026?

(NYSEMKT: MAIA) Maia Biotechnology's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 23.83%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 56.59%.

Maia Biotechnology's earnings in 2025 is -$19,704,460.On average, 1 Wall Street analyst forecast MAIA's earnings for 2025 to be -$21,821,265, with the lowest MAIA earnings forecast at -$21,821,265, and the highest MAIA earnings forecast at -$21,821,265.

In 2026, MAIA is forecast to generate -$20,912,046 in earnings, with the lowest earnings forecast at -$20,912,046 and the highest earnings forecast at -$20,912,046.

If you're new to stock investing, here's how to buy Maia Biotechnology stock.

What is MAIA's revenue growth forecast for 2026-2026?

(NYSEMKT: MAIA) Maia Biotechnology's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 2,804.84%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 49.09%.

Maia Biotechnology's revenue in 2025 is $0.

In 2026, MAIA is forecast to generate $2,008,465,633 in revenue, with the lowest revenue forecast at $2,008,465,633 and the highest revenue forecast at $2,008,465,633.

What is MAIA's forecast return on assets (ROA) for 2025-2026?

(NYSEMKT: MAIA) forecast ROA is -176.26%, which is lower than the forecast US Biotechnology industry average of 10.01%.

What is MAIA's Earnings Per Share (EPS) forecast for 2025-2026?

(NYSEMKT: MAIA) Maia Biotechnology's current Earnings Per Share (EPS) is -$0.79. On average, analysts forecast that MAIA's EPS will be -$0.72 for 2025, with the lowest EPS forecast at -$0.72, and the highest EPS forecast at -$0.72. In 2026, MAIA's EPS is forecast to hit -$0.69 (min: -$0.69, max: -$0.69).

What is MAIA's forecast return on equity (ROE) for 2025-2026?

(NYSEMKT: MAIA) forecast ROE is -423.1%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.